drugset / Trial / NCT00889889
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Immunogenicity and safety of a cell-derived influenza vaccine in adults aged \>= 18 and \<= 64 years, plus revaccination
Timeline
- Start
- 2009-05
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cell-Derived Trivalent Subunit Influenza Vaccine | Vaccine | — | — |